The German pharmaceutical-and-agricultural group said the acquisition would complement its drug pipeline and leverage its ophthalmology footprint.
Source link
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Date:
More like thisRelated
Former coach accused, Rape trial begins, Some rain continues, Downtown dance studio, Sandia Peak Tram anniversary
Wednesday's Top Stories Wednesday's Five Facts Former NM...
How to Increase It in the Era of AI
Brand visibility determines whether your business gets found or...
Nvidia to Invest $500 Million in Corning, Expand Fiber Optic Manufacturing
Nvidia is investing $500 million in Corning as part...